Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Sex Dev. 2022;16(2-3):126-137. doi: 10.1159/000519298. Epub 2021 Oct 25.
MAMLD1 (alias CXorf6) was first documented in 2006 as a causative gene of 46,XY differences/disorders of sex development (DSD). MAMLD1/Mamld1 is expressed in the fetal testis and is predicted to enhance the expression of several Leydig cell-specific genes. To date, hemizygous MAMLD1 variants have been identified in multiple 46,XY individuals with hypomasculinized external genitalia. Pathogenic MAMLD1 variants are likely to cause genital abnormalities at birth and are possibly associated with age-dependent deterioration of testicular function. In addition, some MAMLD1 variants have been identified in 46,XX individuals with ovarian dysfunction. However, recent studies have raised the possibility that MAMLD1 variants cause 46,XY DSD and ovarian dysfunction as oligogenic disorders. Unsolved issues regarding MAMLD1 include the association between MAMLD1 variants and 46,XX testicular DSD, gene-gene interactions in the development of MAMLD1-mediated DSD, and intracellular functions of MAMLD1.
MAMLD1(又名 CXorf6)于 2006 年首次被记录为导致 46,XY 性别发育障碍(DSD)的致病基因。MAMLD1/Mamld1 在胎儿睾丸中表达,并被预测能增强几种睾丸间质细胞特异性基因的表达。迄今为止,半合子 MAMLD1 变体已在多个外生殖器低雄性化的 46,XY 个体中被发现。致病性 MAMLD1 变体可能导致出生时的生殖器异常,并可能与睾丸功能随年龄恶化有关。此外,一些 MAMLD1 变体已在卵巢功能障碍的 46,XX 个体中被发现。然而,最近的研究提出了 MAMLD1 变体作为多基因疾病导致 46,XY DSD 和卵巢功能障碍的可能性。MAMLD1 尚未解决的问题包括 MAMLD1 变体与 46,XX 睾丸 DSD 之间的关联、MAMLD1 介导的 DSD 发育中的基因-基因相互作用以及 MAMLD1 的细胞内功能。